• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺次全切除术及促甲状腺激素抑制在甲状腺乳头状癌初始治疗中的优势

The advantages of subtotal thyroidectomy and suppression of TSH in the primary treatment of papillary carcinoma of the thyroid.

作者信息

Crile G, Antunez A R, Esselstyn C B, Hawk W A, Skillern P G

出版信息

Cancer. 1985 Jun 1;55(11):2691-7. doi: 10.1002/1097-0142(19850601)55:11<2691::aid-cncr2820551126>3.0.co;2-y.

DOI:10.1002/1097-0142(19850601)55:11<2691::aid-cncr2820551126>3.0.co;2-y
PMID:3922611
Abstract

Patients between the ages of 6 and 45 years with distant metastases from papillary carcinoma of the thyroid can be treated as effectively by subtotal thyroidectomy and suppressive doses of thyroid hormone as by total thyroidectomy followed by treatment with iodine 131 (131I). Moreover, distant metastases can be treated by either 131I or suppression as effectively after they are apparent on x-ray as they can be when treated in a subclinical stage. Therefore, in patients younger than 45 years old it is rarely necessary to perform a total thyroidectomy or to do frequent postoperative scans. In patients older than 44 or younger than 7 who have distant metastases or extensive involvement of both lobes, total or almost total thyroidectomy is justified if it can be done with minimal morbidity. In patients of this age group whose tumors fail to respond to suppressive doses of thyroid, 131I should be used. In view of the importance of diagnostic related groups (DRG) to the economy of hospitals, we note that the cost of total thyroidectomy, ablation by 131I, and intermittent body scans is at least three times that of less radical procedures which, in conjunction with suppression by thyroid feeding, give the same survival with less morbidity.

摘要

年龄在6至45岁之间、患有甲状腺乳头状癌远处转移的患者,接受甲状腺次全切除术及甲状腺激素抑制剂量治疗的效果与接受甲状腺全切除术并继以131碘(131I)治疗相同。此外,远处转移在X线显影后,采用131I或抑制治疗的效果与在亚临床阶段治疗时相同。因此,对于年龄小于45岁的患者,很少需要进行甲状腺全切除术或频繁的术后扫描。对于年龄大于44岁或小于7岁、有远处转移或两叶广泛受累的患者,如果能将手术 morbidity降至最低,则进行甲状腺全切除术或几乎全切除术是合理的。对于这个年龄组中肿瘤对甲状腺激素抑制剂量无反应的患者,应使用131I。鉴于诊断相关组(DRG)对医院经济的重要性,我们注意到甲状腺全切除术、131I消融术和间歇性全身扫描的费用至少是较保守手术的三倍,而较保守手术结合甲状腺激素补充治疗,能在降低 morbidity的情况下获得相同的生存率。

相似文献

1
The advantages of subtotal thyroidectomy and suppression of TSH in the primary treatment of papillary carcinoma of the thyroid.甲状腺次全切除术及促甲状腺激素抑制在甲状腺乳头状癌初始治疗中的优势
Cancer. 1985 Jun 1;55(11):2691-7. doi: 10.1002/1097-0142(19850601)55:11<2691::aid-cncr2820551126>3.0.co;2-y.
2
Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.初始手术和药物治疗对乳头状和滤泡状甲状腺癌的长期影响。
Am J Med. 1994 Nov;97(5):418-28. doi: 10.1016/0002-9343(94)90321-2.
3
Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.乳头状和滤泡状甲状腺癌的病理肿瘤-淋巴结-转移(pTNM)分期:700例患者的回顾性分析
J Clin Endocrinol Metab. 1997 Nov;82(11):3553-62. doi: 10.1210/jcem.82.11.4373.
4
Evaluating the prognostic factors associated with cancer-specific survival of differentiated thyroid carcinoma presenting with distant metastasis.评估伴有远处转移的分化型甲状腺癌患者与癌症特异性生存相关的预后因素。
Ann Surg Oncol. 2013 Apr;20(4):1329-35. doi: 10.1245/s10434-012-2711-x. Epub 2012 Oct 28.
5
Improving postoperative recurrence rates for carcinoma of the thyroid gland.提高甲状腺癌术后复发率。
Surg Gynecol Obstet. 1989 Nov;169(5):429-34.
6
A case of stunning of lung and bone metastases of papillary thyroid cancer after a therapeutic dose (3.7 GBq) of 131I and review of the literature: implications for sequential treatments.
Br J Radiol. 2005 May;78(929):428-32. doi: 10.1259/bjr/92548685.
7
Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma.放射性碘治疗及外照射放疗用于甲状腺癌肺和骨转移
J Nucl Med. 1996 Apr;37(4):598-605.
8
Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients.儿童和青少年分化型甲状腺癌:85例患者的37年经验
J Nucl Med. 1997 May;38(5):669-75.
9
Biologic considerations and operative strategy in papillary thyroid carcinoma: arguments against the routine performance of total thyroidectomy.甲状腺乳头状癌的生物学考量与手术策略:反对常规行甲状腺全切除术的理由
Surgery. 1984 Dec;96(6):957-71.
10
[The clinical characteristics and treatment strategies of differentiated thyroid carcinoma in adolescents and children].青少年及儿童分化型甲状腺癌的临床特征与治疗策略
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017 Mar 20;31(6):431-437. doi: 10.13201/j.issn.1001-1781.2017.06.006.

引用本文的文献

1
The effect of long-term thyroid-stimulating hormone suppressive therapy on the gonadal steroid hormones of patients with thyroid carcinoma after surgery.长期促甲状腺激素抑制治疗对甲状腺癌患者术后性腺甾体激素的影响。
Gland Surg. 2017 Oct;6(5):443-452. doi: 10.21037/gs.2017.09.05.
2
Initial treatment of differentiated thyroid carcinoma.
Rev Endocr Metab Disord. 2000 Apr;1(3):139-45. doi: 10.1023/a:1010066728437.
3
Differentiated thyroid cancer long-term impact of initial therapy.分化型甲状腺癌初始治疗的长期影响。
Trans Am Clin Climatol Assoc. 1995;106:151-68; discussion 168-70.
4
Current results of conservative surgery for differentiated thyroid carcinoma.分化型甲状腺癌保守手术的当前结果
World J Surg. 1986 Aug;10(4):612-22. doi: 10.1007/BF01655538.
5
[Prognostic criteria of papillary thyroid cancer. Morphologic clinical analysis of 202 cases of tumor].[甲状腺乳头状癌的预后标准。202例肿瘤的形态学临床分析]
Langenbecks Arch Chir. 1987;371(4):263-80. doi: 10.1007/BF01258974.
6
Adenylate cyclase activity as a predictor of thyroid tumor aggressiveness.
World J Surg. 1988 Aug;12(4):528-33. doi: 10.1007/BF01655441.
7
Papillary thyroid carcinoma: occurrence and types of lymph node metastases.甲状腺乳头状癌:淋巴结转移的发生率及类型
J Endocrinol Invest. 1991 Jul-Aug;14(7):543-9. doi: 10.1007/BF03346863.